Efficacy and safety of the therapy of a disease involving a primary melanoma on a long-term basis ("Health Services Research MELANOMA")

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003715

Enrollment

2000

Registered

2016-01-21

Start date

2008-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C43

Interventions

Group 1: attending physican have to fill in an extensive online questionnaire (e-CRF) for the patient concerning the course and therapy of disease at the point 0, 2 and 4 years after a new diagnosed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient who has been diagnosed with new onset skin cancer (= primary melanoma) in the in the period from 01.04.08-31.06.08

Exclusion criteria

Exclusion criteria: no further information

Design outcomes

Primary

Measure	Time frame
Melanoma primary and continuity care	—

Secondary

Measure	Time frame
Patient contentment	—

Countries

Germany

Contacts

Public ContactFrank Meiß

Universitäts-Hautklinik

frank.meiss@uniklinik-freiburg.de0761 270-67490

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026